1. Home
  2. RCKT vs PBI Comparison

RCKT vs PBI Comparison

Compare RCKT & PBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • PBI
  • Stock Information
  • Founded
  • RCKT 1999
  • PBI 1920
  • Country
  • RCKT United States
  • PBI United States
  • Employees
  • RCKT N/A
  • PBI N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • PBI Office Equipment/Supplies/Services
  • Sector
  • RCKT Health Care
  • PBI Miscellaneous
  • Exchange
  • RCKT Nasdaq
  • PBI Nasdaq
  • Market Cap
  • RCKT 1.3B
  • PBI 1.4B
  • IPO Year
  • RCKT N/A
  • PBI N/A
  • Fundamental
  • Price
  • RCKT $11.74
  • PBI $7.25
  • Analyst Decision
  • RCKT Strong Buy
  • PBI
  • Analyst Count
  • RCKT 11
  • PBI 0
  • Target Price
  • RCKT $50.27
  • PBI N/A
  • AVG Volume (30 Days)
  • RCKT 1.3M
  • PBI 1.6M
  • Earning Date
  • RCKT 11-07-2024
  • PBI 01-30-2025
  • Dividend Yield
  • RCKT N/A
  • PBI 2.75%
  • EPS Growth
  • RCKT N/A
  • PBI N/A
  • EPS
  • RCKT N/A
  • PBI N/A
  • Revenue
  • RCKT N/A
  • PBI $3,224,316,000.00
  • Revenue This Year
  • RCKT N/A
  • PBI N/A
  • Revenue Next Year
  • RCKT $234,928.88
  • PBI N/A
  • P/E Ratio
  • RCKT N/A
  • PBI N/A
  • Revenue Growth
  • RCKT N/A
  • PBI 31.01
  • 52 Week Low
  • RCKT $11.58
  • PBI $3.68
  • 52 Week High
  • RCKT $32.53
  • PBI $8.80
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 27.69
  • PBI 39.14
  • Support Level
  • RCKT $11.58
  • PBI $7.56
  • Resistance Level
  • RCKT $15.00
  • PBI $8.01
  • Average True Range (ATR)
  • RCKT 0.82
  • PBI 0.30
  • MACD
  • RCKT -0.09
  • PBI -0.08
  • Stochastic Oscillator
  • RCKT 4.65
  • PBI 7.51

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About PBI Pitney Bowes Inc.

Pitney Bowes Inc is a technology company that offers e-commerce solutions to its clients. The company provides various products and services such as domestic delivery, return and fulfillment, cross-border shipping solutions, sorting services for large volumes of postal mails, technological solutions to enable digital mailing, shipping, and other services. The company operates through three business segments: Global e-commerce, presort services, and SendTech Solutions. The company generates majority of its revenue from United States.

Share on Social Networks: